RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Monash IVF Group Stock

Monash IVF Group P/E 2025

Monash IVF Group P/E

0

Ticker

MVF.AX

ISIN

AU000000MVF3

WKN

A116LZ

As of Jul 9, 2025, Monash IVF Group's P/E ratio was 0, a 0% change from the -76.41 P/E ratio recorded in the previous year.

The Monash IVF Group P/E history

Monash IVF Group Aktienanalyse

What does Monash IVF Group do?

The Monash IVF Group Ltd is a company in Australia specializing in reproductive medicine. It was founded in 1970 by Professor Gab Kovacs, who is considered one of the pioneers in the field of in-vitro fertilization (IVF). The company's history began in a small laboratory in Melbourne, where the first successful IVF procedures were performed. Over time, Monash IVF grew and expanded its focus to include other reproductive treatments such as donor egg programs, sperm donation, and cryopreservation. Monash IVF Group Ltd has since become a leading provider in Australia, with 19 clinics throughout the country. The company is not only active in Australia but also operates clinics in Malaysia and Vietnam. The business model of Monash IVF Group Ltd is centered around helping couples and individuals fulfill their desire to have children. The company offers a wide range of treatments tailored to the individual needs and circumstances of each patient. Among the services offered are not only IVF, donor egg programs, and sperm donation but also other technologies such as intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD). Monash IVF Group Ltd sees itself as an all-rounder and therefore also offers psychological support and guidance during and after treatments. One of the company's specialties is its comprehensive research work. The Monash IVF Group has a specialized research department actively involved in researching new reproductive technologies. The company collaborates closely with universities and leading scientific institutes to gain the latest insights in this field and achieve the best possible outcomes for its patients. Monash IVF Group Ltd is divided into various divisions, each with different focuses and offerings. The main division is the Monash IVF Clinic, specializing in reproductive health and fertility. Here, all common IVF and fertility treatments are offered. Another division is Monash IVF Fertility Diagnostics, specializing in diagnostics and screening of fertility and reproductive problems. State-of-the-art diagnostic procedures for evaluating male and female fertility are used here. Monash IVF Genomics is another division offering genetic counseling, screening, and diagnostics. Here, couples can determine their genetic risk factors for fertility problems and receive support in making the best possible decisions regarding family planning. In addition to these divisions, Monash IVF Group Ltd also offers specialized services. For example, there is the Monash IVF Donor Program, specializing in the facilitation of anonymous and open donor programs. The Monash IVF DNA Matching can also assist in the search for genetic relatives by utilizing advanced DNA profiling. As a leading company in the field of fertility, Monash IVF Group Ltd offers a wide range of products and services to help couples and individuals fulfill their desire to have children. With a long history of innovation and research, as well as a variety of divisions and offerings, the company is an important provider of reproductive medicine in Australia and beyond. Monash IVF Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Monash IVF Group's P/E Ratio

The Price to Earnings (P/E) Ratio of Monash IVF Group is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Monash IVF Group's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Monash IVF Group is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Monash IVF Group’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Monash IVF Group stock

What is the price-to-earnings ratio of Monash IVF Group?

The price-earnings ratio of Monash IVF Group is currently 0.

How has the price-earnings ratio of Monash IVF Group changed compared to last year?

The price-to-earnings ratio of Monash IVF Group has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Monash IVF Group high compared to other companies?

Yes, the price-to-earnings ratio of Monash IVF Group is high compared to other companies.

How does an increase in the price-earnings ratio of Monash IVF Group affect the company?

An increase in the price-earnings ratio of Monash IVF Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Monash IVF Group affect the company?

A decrease in the price-earnings ratio of Monash IVF Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Monash IVF Group?

Some factors that influence the price-earnings ratio of Monash IVF Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Monash IVF Group pay?

Over the past 12 months, Monash IVF Group paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 9.59 %. For the coming 12 months, Monash IVF Group is expected to pay a dividend of 0.07 AUD.

What is the dividend yield of Monash IVF Group?

The current dividend yield of Monash IVF Group is 9.59 %.

When does Monash IVF Group pay dividends?

Monash IVF Group pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Monash IVF Group?

Monash IVF Group paid dividends every year for the past 13 years.

What is the dividend of Monash IVF Group?

For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 9.55 %.

In which sector is Monash IVF Group located?

Monash IVF Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Monash IVF Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Monash IVF Group from 4/11/2025 amounting to 0.037 AUD, you needed to have the stock in your portfolio before the ex-date on 3/6/2025.

When did Monash IVF Group pay the last dividend?

The last dividend was paid out on 4/11/2025.

What was the dividend of Monash IVF Group in the year 2024?

In the year 2024, Monash IVF Group distributed 0.063 AUD as dividends.

In which currency does Monash IVF Group pay out the dividend?

The dividends of Monash IVF Group are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Monash IVF Group

Our stock analysis for Monash IVF Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Monash IVF Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.